Overview
Metaxalone is a moderate to strong muscle relaxant used in the symptomatic treatment of musculoskeletal pain caused by strains, sprains, and other musculoskeletal conditions. It is marketed by King Pharmaceuticals under the brand name Skelaxin®. Its main mechanism of action is thought to involve general central nervous system depression. Metaxalone is associated with few side effects and is available as a 800 mg scored tablet.
Indication
临床主要用作炎症、外伤等引起的局部肌肉痉挛性疼痛的辅助用药。
Associated Conditions
- Pain
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/03 | Phase 4 | ENROLLING_BY_INVITATION | |||
2024/04/24 | Phase 4 | Completed | |||
2024/04/04 | Phase 4 | Completed | |||
2023/12/05 | Phase 4 | Active, not recruiting | |||
2019/07/01 | Not Applicable | Completed | |||
2017/03/03 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| California Pharmaceuticals, LLC | 70332-330 | ORAL | 800 mg in 1 1 | 1/2/2018 | |
| Advanced Rx Pharmacy of Tennessee, LLC | 80425-0131 | ORAL | 800 mg in 1 1 | 11/10/2022 | |
| Bryant Ranch Prepack | 63629-8014 | ORAL | 800 mg in 1 1 | 5/12/2020 | |
| American Health Packaging | 60687-663 | ORAL | 800 mg in 1 1 | 3/3/2023 | |
| Northwind Pharmaceuticals | 51655-162 | ORAL | 800 mg in 1 1 | 6/17/2014 | |
| Amneal Pharmaceuticals of New York LLC | 53746-553 | ORAL | 800 mg in 1 1 | 1/11/2023 | |
| Quality Care Products, LLC | 55700-911 | ORAL | 800 mg in 1 1 | 11/18/2022 | |
| RedPharm Drug, Inc. | 67296-0993 | ORAL | 800 mg in 1 1 | 1/20/2022 | |
| Advanced Rx Pharmacy of Tennessee, LLC | 80425-0122 | ORAL | 800 mg in 1 1 | 2/8/2023 | |
| Physicians Total Care, Inc. | 54868-6102 | ORAL | 800 mg in 1 1 | 5/17/2011 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.